| Title |
The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
|
|---|---|
| Published in |
BMC Cancer, December 2018
|
| DOI | 10.1186/s12885-018-5126-7 |
| Pubmed ID | |
| Authors |
Marilena Petrera, Laura Paleari, Matteo Clavarezza, Matteo Puntoni, Silvia Caviglia, Irene Maria Briata, Massimo Oppezzi, Eva Mihajlovic Mislej, Borut Stabuc, Michael Gnant, Thomas Bachleitner-Hofmann, Wilfried Roth, Dominique Scherer, Walter-E. Haefeli, Cornelia M. Ulrich, Andrea DeCensi |
Mendeley readers
The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 114 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 18% |
| Researcher | 13 | 11% |
| Other | 7 | 6% |
| Student > Master | 7 | 6% |
| Student > Doctoral Student | 6 | 5% |
| Other | 20 | 18% |
| Unknown | 40 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 32% |
| Biochemistry, Genetics and Molecular Biology | 9 | 8% |
| Nursing and Health Professions | 8 | 7% |
| Sports and Recreations | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Other | 12 | 11% |
| Unknown | 41 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2023.
All research outputs
#7,756,853
of 23,578,918 outputs
Outputs from BMC Cancer
#2,148
of 8,483 outputs
Outputs of similar age
#156,686
of 439,761 outputs
Outputs of similar age from BMC Cancer
#50
of 217 outputs
Altmetric has tracked 23,578,918 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,483 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.